Thursday's After-Hours: Intel, Schlumberger Move Following Earnings

By: via Benzinga
Depomed Inc. (NASDAQ: DEPO) +5% - Acquired U.S. rights to NUCYNTA From Johnson & Johnson. Bank Of The Ozarks ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.